Abstract
Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.
Publication types
-
Biography
-
Historical Article
-
Portrait
MeSH terms
-
Bacterial Vaccines / history*
-
Bacterial Vaccines / therapeutic use
-
History, 19th Century
-
History, 20th Century
-
Humans
-
Sarcoma / therapy*
-
Soft Tissue Neoplasms / therapy*
-
Tumor Necrosis Factor-alpha / therapeutic use
Substances
-
Bacterial Vaccines
-
Tumor Necrosis Factor-alpha